feed,title,long_url,short_url
Benzinga,"Gene Therapy Company Genprex, Inc. (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate",https://benzinga.com/partner/23/07/33164608/gene-therapy-company-genprex-inc-nasdaq-gnpx-receives-fast-track-designation-from-the-fda-for-its-sm,https://da.gd/j547LG
